Correlation Between Milestone Pharmaceuticals and Cytokinetics
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Cytokinetics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Cytokinetics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Cytokinetics, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Cytokinetics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Cytokinetics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Cytokinetics.
Diversification Opportunities for Milestone Pharmaceuticals and Cytokinetics
-0.09 | Correlation Coefficient |
Good diversification
The 3 months correlation between Milestone and Cytokinetics is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Cytokinetics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cytokinetics and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Cytokinetics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cytokinetics has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Cytokinetics go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and Cytokinetics
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to generate 1.19 times more return on investment than Cytokinetics. However, Milestone Pharmaceuticals is 1.19 times more volatile than Cytokinetics. It trades about 0.16 of its potential returns per unit of risk. Cytokinetics is currently generating about 0.0 per unit of risk. If you would invest 152.00 in Milestone Pharmaceuticals on August 30, 2024 and sell it today you would earn a total of 35.00 from holding Milestone Pharmaceuticals or generate 23.03% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. Cytokinetics
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| Cytokinetics |
Milestone Pharmaceuticals and Cytokinetics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and Cytokinetics
The main advantage of trading using opposite Milestone Pharmaceuticals and Cytokinetics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Cytokinetics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytokinetics will offset losses from the drop in Cytokinetics' long position.The idea behind Milestone Pharmaceuticals and Cytokinetics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Cytokinetics vs. Edgewise Therapeutics | Cytokinetics vs. Dyne Therapeutics | Cytokinetics vs. Stoke Therapeutics | Cytokinetics vs. Pliant Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |